Product Catalog
90+ peptides. One quality system.
Lyophilized vials at ≥99% HPLC purity, batch-specific COAs, sequence verification on request. Bulk pricing and OEM available.
Already know the peptide name? Browse the full A-Z directory.
34 SKUs · alphabetical · sticky letter strip · direct links to specs.
Browse by category
Metabolic & GLP-1
Tirzepatide, Semaglutide, Retatrutide, Cagrilintide and related GLP-1 / GIP / GCG receptor agonists for metabolic and weight-management research.
Browse
Repair Peptides
BPC-157, TB-500 and related repair-focused peptides for tendon, gastrointestinal mucosa, and soft-tissue research applications.
Browse
Longevity Peptides
Epitalon, GHK-Cu, and other anti-aging research peptides supporting telomere, collagen and circadian-rhythm research lines.
Browse
Cognitive & Neuropeptides
Semax, Selank, DSIP, and related neuropeptides for cognitive, mood, and sleep research applications.
Browse
Cosmetic & Beauty Peptides
GHK-Cu, Snap-8, Matrixyl, AHK-Cu for cosmetic formulators, med spa brands, and beauty OEMs.
Browse
Immune & Anti-Inflammatory
KPV, LL-37, Thymalin, Thymosin Alpha-1, research peptides supporting immune-modulation and antimicrobial research.
Browse
Mitochondrial Peptides
MOTS-c, SS-31 (Elamipretide) and related mitochondrial-targeted research peptides.
Browse
GH-Axis Peptides
CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, GHRP-2/6 and other growth-hormone-axis research peptides and blends.
Browse
Custom Blends & OEM
CagriSema, CJC+IPA, Wolverine Blend, GLOW Blend, custom-ratio multi-peptide formulations.
Browse
All products
34 peptides · live catalog
Tirzepatide
≥99.0%GIP / GLP-1 dual receptor agonist
- CAS
- 2023788-19-2
- Vial
- 2 mg–120 mg
Retatrutide
≥99.0%GIP / GLP-1 / glucagon tri-agonist
- CAS
- 2381089-83-2
- Vial
- 5 mg–60 mg
Semaglutide
≥99.0%GLP-1 receptor agonist
- CAS
- 910463-68-2
- Vial
- 2 mg–50 mg
Cagrilintide
≥99.0%Long-acting amylin analog
- CAS
- 1415456-99-3
- Vial
- 2 mg–10 mg
15-mer
BPC-157
≥99.0%Body Protection Compound 15-mer
- CAS
- 137525-51-0
- Vial
- 2 mg–10 mg
43-mer
TB-500
≥99.0%Thymosin β4 fragment
- CAS
- 885340-08-9
- Vial
- 2 mg–10 mg
3-mer
GHK-Cu
≥99.0%Copper tripeptide-1
- CAS
- 89030-95-5
- Vial
- 50 mg · 100 mg
16-mer
MOTS-c
≥99.0%Mitochondrial-derived peptide
- CAS
- 1627580-64-6
- Vial
- 10 mg–40 mg
3-mer
KPV
≥99.0%Lys-Pro-Val α-MSH C-terminal tripeptide
- CAS
- 67727-97-3
- Vial
- 5 mg · 10 mg
CJC-1295 + Ipamorelin
≥99.0%GH-axis blend (CJC-1295 no DAC + Ipamorelin)
- CAS
- —
- Vial
- 10 mg
CJC-1295 (no DAC)
≥99.0%Modified GRF 1-29 · GHRH analog
- CAS
- 863288-34-0
- Vial
- 2 mg–10 mg
Ipamorelin
≥99.0%Ghrelin / GHSR pathway GH-release peptide
- CAS
- 170851-70-4
- Vial
- 2 mg–10 mg
29-mer
Sermorelin
≥99.0%GHRH 1-29 fragment
- CAS
- 86168-78-7
- Vial
- 2 mg–10 mg
AOD9604
≥99.0%Modified HGH fragment 176–191 (anti-obesity drug candidate)
- CAS
- 221231-10-3
- Vial
- 2 mg–10 mg
16-mer
HGH Fragment 176-191
≥99.0%C-terminal fragment of human growth hormone (176–191)
- CAS
- 66004-57-7
- Vial
- 1 mg–15 mg
Tesamorelin + Ipamorelin Blend (15 mg)
≥99.0%GH-axis blend (Tesamorelin + Ipamorelin), 15 mg total
- CAS
- —
- Vial
- 15 mg
CJC-1295 with DAC
≥99.0%Long-acting GHRH analog with Drug Affinity Complex
- CAS
- 863288-34-0
- Vial
- 2 mg · 5 mg
GHRP-2
≥99.0%Growth-hormone-releasing peptide-2 · Pralmorelin
- CAS
- 158861-67-7
- Vial
- 5 mg · 10 mg
GHRP-6
≥99.0%Growth-hormone-releasing peptide-6
- CAS
- 87616-84-0
- Vial
- 5 mg · 10 mg
29-mer
Tesamorelin
≥99.0%GHRH analog · approved for HIV-associated lipodystrophy
- CAS
- 218949-48-5
- Vial
- 2 mg–20 mg
Liraglutide
≥99.0%GLP-1 receptor agonist (long-acting)
- CAS
- 204656-20-2
- Vial
- 5 mg–30 mg
Mazdutide
≥99.0%GLP-1 / glucagon dual receptor agonist (IBI362 / LY3305677)
- CAS
- 2252403-56-6
- Vial
- 10 mg
Survodutide
≥99.0%GLP-1 / glucagon dual receptor agonist (BI 456906)
- CAS
- 2365457-03-9
- Vial
- 10 mg
PEG-MGF
≥99.0%PEGylated Mechano Growth Factor
- CAS
- 108174-48-7
- Vial
- 2 mg–10 mg
CagriSema
≥99.0%Cagrilintide + Semaglutide combination
- CAS
- —
- Vial
- 5 mg–20 mg
HCG (Human Chorionic Gonadotropin)
≥99.0%Gonadotropin glycoprotein hormone · heavily regulated
- CAS
- 9002-61-3
- Vial
- 1000 IU–10 mg
HMG (Human Menopausal Gonadotropin / Menotropins)
≥99.0%FSH / LH-active gonadotropin · heavily regulated
- CAS
- 9002-68-0
- Vial
- 75 IU
IGF-1 LR3
≥99.0%Long-Arg3 IGF-1 (long-acting IGF-1 analog)
- CAS
- 946870-92-4
- Vial
- 100 mcg–2 mg
MGF (Mechano Growth Factor)
≥99.0%IGF-1 Ec splice-variant peptide
- CAS
- —
- Vial
- 2 mg
HGH (Somatropin · Human Growth Hormone)
≥99.0%Recombinant human growth hormone · heavily regulated biological
- CAS
- 12629-01-5
- Vial
- 6 IU–40 IU
BAC Water (Bacteriostatic Water for Injection)
≥99.0%0.9% benzyl-alcohol bacteriostatic water
- CAS
- —
- Vial
- 3 ml · 10 ml
Saline (0.9% Sodium Chloride Injection)
≥99.0%0.9% isotonic sodium-chloride reconstitution diluent
- CAS
- —
- Vial
- 3 ml · 10 ml
Sterile Water for Injection
≥99.0%Preservative-free sterile water reconstitution diluent
- CAS
- 7732-18-5
- Vial
- 3 ml · 10 ml
Acetic Acid (Glacial / Concentrated Solvent)
≥99.0%Acidification solvent · process auxiliary
- CAS
- 64-19-7
- Vial
- 10 ml